Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 198.61 | 131.23 | 102.01 | 118.93 |
Total Revenue | 198.61 | 131.23 | 102.01 | 118.93 |
Costof Revenue Total | 146.26 | 92.20 | 59.43 | 67.56 |
Gross Profit | 52.35 | 39.03 | 42.58 | 51.37 |
Selling/ General/ Admin Expenses Total | 11.26 | 11.29 | 10.88 | 11.06 |
Depreciation/ Amortization | 3.23 | 3.71 | 2.25 | 2.52 |
Other Operating Expenses Total | 28.47 | 15.96 | 23.98 | 31.57 |
Total Operating Expense | 189.22 | 123.16 | 96.55 | 112.71 |
Operating Income | 9.39 | 8.07 | 5.46 | 6.22 |
Interest Inc( Exp) Net- Non- Op Total | -29.03 | -30.70 | -19.54 | -17.66 |
Gain( Loss)on Saleof Assets | 5.03 | 0.00 | 0.40 | 0.55 |
Other Net | 1.11 | 0.60 | 0.22 | 0.42 |
Net Income Before Taxes | 8.11 | 5.60 | 3.77 | 4.93 |
Provisionfor Income Taxes | 2.09 | 1.53 | 0.95 | 1.22 |
Net Income After Taxes | 6.02 | 4.07 | 2.81 | 3.70 |
Net Income Before Extra Items | 6.02 | 4.07 | 2.81 | 3.70 |
Net Income | 6.02 | 4.07 | 2.81 | 3.70 |
Income Availableto Com Excl Extra Ord | 6.02 | 4.07 | 2.81 | 3.70 |
Income Availableto Com Incl Extra Ord | 6.02 | 4.07 | 2.81 | 3.70 |
Diluted Net Income | 6.02 | 4.07 | 2.81 | 3.70 |
Diluted Weighted Average Shares | 1.71 | 1.20 | 1.71 | 1.71 |
Diluted EPS Excluding Extra Ord Items | 3.51 | 3.39 | 1.64 | 2.16 |
Diluted Normalized EPS | 3.29 | 3.39 | 1.62 | 2.14 |
Crop Life Science Dividend Crop Life Science Bonus Crop Life Science News Crop Life Science AGM Crop Life Science Rights Crop Life Science Splits Crop Life Science Board Meetings Crop Life Science Key Metrics Crop Life Science Shareholdings Crop Life Science Balance Sheet Crop Life Science Cashflow Crop Life Science Q1 Results Crop Life Science Q2 Results Crop Life Science Q3 Results Crop Life Science Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks